Transcript Document

Dried Blood Spots
Acknowledgements
Dr. Rachanee Chiengasong
Kyle Bond
Dr. Marie Downer
Dr. Joanne Mei
Debbie Kuehl
Debbie Candal
Dr. Mark Rayfield
Dr. Bharat Parekh
Dr. Harry Hannon
Steve Soroka
Dr. Rich Respess
Trudy Dobbs
Dried Blood Spots (DBS)

AKA



Guthrie cards
Filter paper disks
Applications


Antibody testing
DNA/RNA
Amplifications
Advantages of DBS
Easy to collect, store, and transport
 Stable
 Adaptable to a variety of techniques
 Quality protocols already developed
 Centralized testing
 Whole blood matrix
 Safety

Disadvantages of DBS
Skin puncture required
 Small sample volume
 Dilution for analysis
 Suitability for confirmatory method
 Clinical sanction of data

Analytes Measured in Dried Human Blood
on Filter Paper ~ 1
Acarboxyprothrombin
Acylcarnitine
Adenine phosphoribosyl transferase
Adenosine deaminase
Albumin
a-fetoprotein
Amino Acids
profiles
arginine (Krebs cycle)
histidine/urocanic acid
homocysteine
phenylalanine/tyrosine
tryptophan
Andrenostenedione
Antipyrine
Arabinitol enantiomers
Arginase
Benzoylecgonine (cocaine)
Biotinidase
Biopterin
C-reactive protein
Carnitine
Carnosinase
CD4
Ceruloplasmin
Chenodeoxycholic acid
Chloroquine
Cholesterol
Cholinesterase
Conjugated 1-b hydroxycholic acid
Cortisol
Creatine kinase
Creatine kinase MM isoenzyme
Cyclosporin A
D-penicillamine
De-ethylchloroquine
Dehydroepiandrosterone sulfate
DNA (PCR)
acetylator polymorphism
alcohol dehydrogenase
a 1-antitrypsin
cystic fibrosis
Duchenne/Becker
muscular dystrophy
glucose-6-phosphate
dehydrogenase
hemoglobinopathies
A,S,C,E
D-Punjab
beta-thalassemia
hepatitis B virus
HCMV
HIV-1
HTLV-1
Analytes Measured in Dried Human Blood
on Filter Paper
~2
Leber hereditory optic
Glutathione perioxidase
neuropathy
MCAD
mRNA
PKU
Plasmodium vivax
sexual differentiation
21-deoxycortisol
Desbutylhalofantrine
Dihydropteridine reductase
Diptheria/tetanus antitoxin
Erythrocyte arginase
Erythrocyte protoporphyrin
Esterase D
Fatty acids/acylglycines
Free b-human chorionic
gonadotropin
Free erythrocyte prophyrin
Free thyroxine (FT4)
Free tri-iodothyroine (FT3)
Fumarylacetoacetase
Galactose/gal-1-phosphate
Galactose-1-phosphate uridyl transferase
Gentamicin
Glucose
Glucose-6-phosphate dehydrogenase
Glutathione
Glycocholic acid
Glycosylated hemoglobin
Halofantrine
Hemoglobin variants
Hexosaminidase A
Human erythrocyte carbonic anhydrase I
17-a hydroxyprogesterone
Hypoxanthine phosphoribosyl transferase
Immunoreactive trypsin (CF)
Lactate
Lead
Lipoproteins
(a)
B/A-1
b
Lysozyme
Mefloquine
Netilmicin
Phenobarbitone
Phenytoin
Phytanic/pristanic acid
Progesterone
Prolactin
Prolidase
Analytes Measured in Dried Human Blood
on Filter Paper ~ 3
Purine nucleoside phosphorylase
Quinine
Reverse tri-iodothyronine (rT3)
Selenium
Serum pancreatic lipase
Sissomicin
Somatomedin C
Specific antibodies
adenovirus
anti-nuclear antibody
anti-zeta antibody
arbovirus
Aujeszky’s disease virus
dengue virus
Dracunculus medinensis
Echinococcus granulosus
Entamoeba histolytica
enterovirus
Giardia duodenalisa
Helicobacter pylori
hepatitus B virus
herpes virus
HIV-1
IgE (atopic disease)
influenza virus
Leishmania donovani
leptospira
measles/mumps/rubella
Mycobacterium leprae
Mycoplasma pneumoniae
Onchocerca volvulus
parainfluenza virus
Plasmodium falciparum
poliovirus
Pseudomonas aeruginosa
respiratory syncytial virus
rickettsia (scrub typhus)
Schistosoma mansoni
Toxoplasma gondii
Trepenoma pallidium
Trypanosoma cruzi/rangeli
vesicular stomatis virus
Wuchereria bancrofti
yellow fever virus
Spectic antigens
hepatitis B virus
HIV-1
Succinylacetone
Sulfadoxine
Theophylline
Thyrotropin (TSH)
Throxine (T4)
Thyroxine-binding globulin
Trace elements
Transferrin
UDP-galactose-4-epimerase
Urea
Uroporphyrinogen I synthase
Vitamin A
White blood cells
Zinc protoporphyrin
Applications of DBS for HIV testing
Surveillance
 Quality control for HIV rapid testing
 Quantitation of HIV viral load
 Identification of HIV infected infants

Dried Blood Spots (DBS) Characteristics
Fingerstick or whole blood draw
 Placed onto special collection papers
 Dried properly
 Stored appropriately
 Inspected for quality

Tenderfoot® Lancet for Heel Sticks






Safe for obtaining blood
samples from heels of infants.
A surgical blade incises to a
standardized depth and length
An incision created to allow
blood to flow freely
A higher quality blood sample
is collected and bruising is
diminished.
Blade permanently retracts
after use for safety
Available in three incision
depths for preemies, toddlers
and full term infants.
Tenderlett® Lancet for Finger Sticks





Incision device with blade that
cuts to a controlled,
standardized depth.
Shallow incision created which
cuts more of the capillary bed
without cutting too deeply.
Blood flows more freely
providing a higher quality
blood specimen.
Blade permanently retracts
after use for safety
Available in three depths for
the appropriate patient
population.
Instructions for Specimen Collection:










Do not touch any of the filter paper circle before or after collection.
Select puncture site and cleanse with 70% isopropanol.
Use a sterile, disposable lancet with 2.0 mm, or less, point
Keep heel in down position at or below heart level.
Wipe away first blood drop.
Use second LARGE blood drop to apply to surface of filter paper
circle.
If not completely filled, add a second LARGE drop immediately.
FILL all required circles completely. FILL from only one side of the
filter paper.
Dry specimen at room temperature 3-4 hours in HORIZONTAL
position.
IMPROPERLY COLLECTED SAMPLES MUST BE REJECTED.
Tips for Specimen Collection:





Complete each item on the collection form.
Closely follow the collection instructions on the request
form.
Warm heel with a warm towel and hold heel at or below the
heart.
Fill one circle at a time.
If capillaries are used to transfer blood from heel to paper:
 Capillaries must be heparinized (Do not use EDTA).
 Mix capillaries well before applying blood to filter paper.
 Apply blood to filter paper immediately after filling.
 Do not touch capillary to filter paper.
Collection Problems
DBS -- HIV Antibody detection
Quality of collection
 Antibody elution
 Optimization of enzyme immunoassay (EIA) -washing, temperature, elution, mixing
 Development of miniaturized Western blot for
confirmation

Assay Optimization





Optimal antibody elution
Determination of effective specimen dilution
Assessment of antibody detection
 Strongly reactive samples
 Weakly reactive samples, seroconversion
 Non-reactive samples
 Others – HIV-2, subtypes?
Assay modifications
Number of tests to perform
DRIED BLOOD SPOT PUNCHES
ARE VOLUMETRIC MEASUREMENTS
EQUALS
Require the Same Accuracy and Precision
POTENTIAL ALIQUOT VARIABILITY
WITH DRIED-BLOOD SPOT SPECIMENS
10 µL
10 µL
=

6 mm punch
6 mm punch
Typical EIA Assay Procedure for Dried Blood
Spots
Punch 3 or 6 mm disks into microwell plate
Elution Plate
1.
2.
3.
4.
Add Kit Diluent (150 uL, 1:30)
Cover plate, incubate overnight at 4oC
Shake plate gently to mix
Add Diluent to assay plate (125 uL)
5.
Transfer DBS eluate (25 uL) to assay plate
(1:150 final serum dilution)
Assay Plate
1.
2.
3.
4.
5.
6.
7.
8.
Cover plate, incubate plate 90 min at 37oC
Wash plate 4x
Add IgG-Enzyme Conjugate
Cover plate, incubate 30 min at 37oC
Add Substrate (150 uL)
Incubate 10 min at 25oC
Add Stop Solution (150 uL)
Read plate at 405 nm
Variable Affecting Measurements for
Specimens Collected on Filter Paper
Homogeneity within a production lot
 Homogeneity among production lots
 Variance among manufacturers
 Variance within a collection card
 Cutting and printing process

Variable Affecting Measurements for
Specimens Collected on Filter Paper
Handling and storage of paper
 Humidity condition of paper
 Volume of blood collected
 Hematocrit level of blood donor
 Absorption time for blood

Hematocrit
Effect
Hematocrit Effect
lo
in
c
12
11
4
B
S&S / Whatman Comparison
/
10
L
1
1515
9
u
/
1414
1313
d
8
30
o
1212
40
50
60
% Hematocrit
lo
L Blood per 1/4 inch punch
S&S / Whatman Comparison
30 1111
40
50
B
% Hematocrit
1010
L
70
S&S Lot W961
Whatman Lot 641
S&S Lot W961
Whatman
Lot6411
6411
Whatman Lot
S&S Lot W961
u
99
60
88
30
30
40
40
50
50
60
60
70
70
% Hematocrit
Percent Hematocrit (100L blood spot)
S&S Lot W961
Whatman Lot 6411
l
B
in c h
Spot Volume
Spot Volume
S&S10 / Whatman Comparison
S&S / Whatman Comparison
L
15
14
u
1 / 4
9
14
/
8
30
lo o d
13
13
40
40
50
60
% Hematocrit
B
11
50
60
% Hematocrit
12
12
u L
L Blood per 1/4 inch punch
30
11
S&S Lot W961
70
S&SLot
Lot
W961
S&S
W961
Whatman
Lot6411
6411
Whatman Lot
10
11
25
25
50
50
75
75
100
100
125
125
SpotVoulme
Volume (uL) (L)
Blood Spot
(55% hematocrit)
S&S Lot W961
Whatman Lot 6411
Whatman Lot 64
Schleicher and Schuell Grade 903 Filter Paper
Lysed Red Blood Cells
1.7
Serum Volume per 1/8” Punch (L)
1.6
99%
1.5
95%
1.4
_
X
1.3
1.2
95%
1.1
99%
1.0
0.9
W
2
1
W
2
2
W
3
1
W
3
2
W
4
1
W
5
2
W
8
5
3
W
8
7
1
W
8
7
2
W
8
8
1
W
8
9
1
W
9
0
1
Lot Numbers In Chronological Order
W
9
2
1
W
9
3
2
W
9
4
1
W
9
6
1
W
9
8
1
Optimization of DBS EIA
Sample distribution DBS vs. Serum
Frequency
Serum
DBS
45
40
35
30
25
20
15
10
5
0
0.1
0.3
0.5
0.99
2
Signal/Cutoff Ratio
N=108
5
>10
DBS EIA Performance




Sensitivity -- 100%
Specificity -- 99.8%
False positive rate -- 0.15%
Repeat reactive specimens WB
confirmed -- 47%
Gold Standard
Positive
Negative
Positive
True positives
A
False negatives
B
Negative
False positives
C
True negatives
D
New
Test

Establishment of
performance
characteristics





Sensitivity = A / A+C
Specificity = D / B+D
PVP = A / A+B
NVP = D / C+D
Efficiency = A+D / A+B+C+D
Prevalance = A+C / A+B+C+D
DBS EIA problems
Insufficient washing
 Spot quality
 Incubation temperature
 Elution/air bubbles
 Splashing

DBS Western Blot Performance




Miniaturization of methods for low sample volumes
Reduction of background reactivity
Assay optimization
Presence of non-viral bands
Detection of HIV antibodies on
miniaturized Western blot
gp160
gp120
p66
p55/51
gp41
p31
p24
p17
Quality Control for DBS






Evaluation of kit controls
DBS controls performed in duplicate
All DBS controls must be properly classified
Low DBS controls monitor EIA performance and eluate
stability
High DBS controls may be used as Western blot controls
High DBS controls should be included with frozen specimens
to monitor long-term stability
Quality Control for DBS (Cont.)
Specimens should be separated from the filter
paper if testing will not be completed immediately
 Specimens should be stored in microvolume tubes
with caps equipped with rubber gaskets.
 Store short-term at 4oC and long-term and –20oC

Blank wells for serum controls
(must follow configuration of plate
as directed by EIA kit)
Dried Blood Spot (DBS) controls
in duplicate: High Positive (HPC)
Low Positive (LPC)
Negative (NC)
Initial EIA
If spots are not white after
elution, insufficient elution may
have occurred. Record
observations.
Elution Plate with Initially
REACTIVE EIA Samples
Retrieve reactive
eluates from each plate
Retrieve eluates of each DBS
control from each plate
Transfer eluates to microtubes; store at 4oC
Repeat EIA in duplicate on all reactive
Samples and on DBS LPC in tandem
If EIA plate consists only of repeat
DBS samples, a set of new DBS
controls is not required; load serum
controls as directed by kit.
REPEAT EIA
RESULTS
INTERPRETATION AND ACTION
Both DBS LPC’s
reactive, both sample
replicates nonreative
Report as NEGATIVE
IMMUNOBLOT
Both DBS LPC’s
reactive, one or both
replicates from same
elution plate reactive
Repeatedly reactive
ALL repeatedly reactive eluates
One or both DBS LPC’s from
original elution plate
nonreactive; results of
eluates from this elution plate
may be unreliable
Suspect repeat EIA
ANY eluates with suspect
repeat EIA results
CONTROLS
DBS HPC eluates from
oldest elution plate
Serum HPC, LPC and NC
on each membrane
DBS Collection Forms
Detection of antibodies to other
viruses in DBS eluates
HTLV-I
 Hepatitis A, B, and C
 Measles, mumps and rubella
 Dengue

Detection of Viral Nucleic Acid
on DBS



Extraction procedures

Boiling

Phenol/Chloroform

Glass beads/powder
Amplification protocols

Single step DNA PCR

Nested DNA PCR

RT-PCR
Precautions

Contamination

Removal of inhibitors
 Chelex 100
 Proteinase K
Detection of Viral Nucleic Acid
on DBS - Applications
HIV-1
 Subtypes
 CMV
 Hepatitis C
 HTLV-I
